Prescribing Guidance and Standards for Healthcare Professionals for Health Practitioners facing an Ahpra notification, complaint or allegation

The prescription reconstructed, the step missed and the change. The script is already in evidence, so the response is built on why: the indication and the alternatives considered, what the patient was told, the dose and duration, the monitoring planned — read against the pharmacy record and the monitoring system, and labelled as a later reflection wherever it was not recorded at the time. Then the step missed, named from your own code or your state’s rules, the effect on the patient, and what now stands behind it: an audit, the monitoring system used, a review cycle, each dated.

Yes, and before you answer any of the bodies a prescribing matter can involve. Your indemnity insurer or defence organisation is the first call, and a lawyer should read the response before it goes to Ahpra or your National Board, your profession’s Council of NSW or the HCCC, the OHO, your state or territory’s drugs and poisons regulator, a Medicare or PBS process, or a panel or tribunal. Clause 7.2 of the shared code itself tells you to seek advice when you are not sure what to do. Nothing on this page is legal advice, and no course determines the outcome of a notification.

Yes, and the remediation produces its own evidence: an audit repeated, the monitoring system used, a review cycle, a deprescribing plan. No provider is accredited by Ahpra or any National Board, and no course decides a matter. What the Board, a panel and a tribunal weigh is dated, targeted remediation with reflection that engages the standard — and this course covers rational prescribing, high-risk medicines, real-time monitoring, telehealth prescribing and deprescribing, with five Australian case studies, so the connection is plain on the certificate and in your reflective account. Check the wording of any condition, undertaking or direction with your indemnity insurer or defence organisation, your union or professional association or a lawyer before you rely on it.

After an assessment or an investigation your Board may take no further action, caution you, accept an undertaking or impose conditions — a restriction on prescribing a class of medicine, supervision, education, an audit (section 178) — require a health or performance assessment (sections 169 and 170), refer you to a panel, or refer the most serious matters to a tribunal (section 193), which can reprimand, impose conditions, fine, suspend, cancel registration and disqualify (section 196). The tribunals have suspended prescribers for prescribing to family and to themselves, and ordered mentoring, education, audits and drug screening.

Not Ahpra, in either case. In New South Wales your profession’s Council of NSW and the Health Care Complaints Commission manage conduct, health and performance matters between them, and Ahpra does not investigate registered practitioners there. In Queensland every complaint goes first to the Office of the Health Ombudsman, which decides what it keeps and what it refers on to Ahpra and the Board. The letterhead tells you which body has your file, and the same response — the reasoning, the standard, the remediation — is what each of them reads for. A prescribing matter can also be with your state or territory’s drugs and poisons regulator at the same time — in New South Wales, the Pharmaceutical Regulatory Unit.

For doctors, Good medical practice (4.15) is a prohibition rather than advice for the highest-risk medicines: a doctor must not prescribe Schedule 8 medicines, psychotropic medication or drugs of dependence to anyone with whom they have a close personal relationship. For the shared-code professions, clause 4.8 sets conditions rather than a ban — an adequate assessment, records, consent acknowledged by you both — and clause 9.1 refers self-prescribing to your state or territory’s law. Nurse practitioners and endorsed midwives answer to the NMBA codes. Whatever your profession, take advice before writing one, not after.

It is set by state and territory law, not nationally. Every state and territory now runs a system — SafeScript in Victoria, SafeScript NSW, QScript, Canberra Script, ScriptCheckSA, ScriptCheckWA, TasScript and NTScript — and whether checking before prescribing a monitored medicine is mandatory, and which medicines are monitored, are set by each of them. Check your own jurisdiction’s rule rather than the one you trained under, and record the check when you make it: a response that says a check was made is read against the system’s log.

It is relevant context and it is not an answer. The course states plainly that inappropriate prescribing due to patient pressure may be judged as unsafe practice. What does help is showing how you managed the request: the clinical reasoning you explained, the alternatives you offered, the decision shared, and the discussion documented. Declining well is a skill the course teaches directly, and for an antibiotic clause 6.3 of the shared code makes appropriate use of antimicrobials a public-health duty, not only a matter for the consultation in front of you.

Yes. Clause 4.5 of the shared code asks you, when something has gone wrong, to act to put it right, explain to the patient as promptly and fully as possible what happened and what it means for them, acknowledge any distress, and review the event to reduce the risk of recurrence; Good medical practice (4.11) and the NMBA codes say the same. The course teaches that conversation, and records that practitioners who show honesty and insight are viewed as far lower risk. Speak to your indemnity insurer about how and when, and record the conversation the same day.

Yes. A Board notification is separate from your state or territory’s drugs and poisons regulator, and both are separate again from a Medicare or PBS compliance process. They can proceed in parallel, on different timetables, and something said in one may be seen in another. One consistent account serves all of them, written after advice and checked against the pharmacy record and the monitoring system before it goes. The course sets out what a breach of the prescribing rules can bring: a notification to Ahpra, a Medicare audit or sanctions, disciplinary action, the loss of prescribing rights.

No. The course is explicit that telehealth prescribing must meet the same standards as face-to-face practice, and the Board guidance says the same. The failures the course names are the ones a notification describes: an assessment that would not have been adequate in person, identity not confirmed, a high-risk medicine prescribed without appropriate review, the monitoring system not checked. A telehealth script is answered like any other — the indication, the assessment, the check and the record — and the platform is not part of the answer.

They overlap at medication error, and they are often taken together. This course is about the medicine: the indication written down, high-risk medicines and monitoring, real-time prescription monitoring, interactions and allergies, deprescribing, antibiotics under pressure and telehealth scripts. Ensuring Clinical Competence and Patient Safety is about clinical reasoning across the whole of care — assessment, diagnosis, deterioration, follow-up, escalation and scope. If the letter is about a script, start here; if it is about a diagnosis or a deterioration, start there.

Each National Board sets its own continuing professional development registration standard, and targeted CPD on the subject of a notification is among the remediation the Board and the tribunals recognise. The certificate records the course, the 2 CPD hours and the date, which is what a CPD portfolio needs; how the hours count towards your requirement depends on the standard’s categories, so check them.

The course is 2 CPD hours, self-paced, with twelve months’ access from purchase. The certificate is issued on completion, dated, with the course title and the CPD hours, for a response, a portfolio or your CPD record.